BIOLOGICAL MARKERS IN SUPERFICIAL BLADDER TUMORS AND THEIR PROGNOSTIC SIGNIFICANCE
- 1 February 2000
- journal article
- review article
- Published by Elsevier in Urologic Clinics of North America
- Vol. 27 (1) , 179-189
- https://doi.org/10.1016/s0094-0143(05)70246-9
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Alterations of TP53 in microdissected transitional cell carcinoma of the human urinary bladder: high frequency of TP53 accumulation in the absence of detected mutations is associated with poor prognosisBritish Journal of Cancer, 1998
- Frequent and heterogenous expression of cyclin-dependent kinase inhibitor WAF1/p21 protein and mRNA in urothelial carcinomaBritish Journal of Cancer, 1998
- Prognostic Value of Ki-67 for Recurrence and Progression of Superficial Bladder CancerJournal of Urology, 1997
- Nuclear accumulation of mutant p53 protein: a possible predictor of failure of intravesical therapy in bladder cancerBritish Journal of Urology, 1997
- Assessing p53 Status in Breast Cancer Prognosis: Where Should You Put the Thermometer If You Think Your p53 Is Sick?JNCI Journal of the National Cancer Institute, 1996
- Cancer progression and p53The Lancet, 1995
- Mice Lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint controlCell, 1995
- Accumulation of Nuclear p53 and Tumor Progression in Bladder CancerNew England Journal of Medicine, 1994
- p53 mutations in human bladder cancer: Genotypic versus phenotypic patternsInternational Journal of Cancer, 1994
- Monoclonal antibodies against recombinant parts of the Ki‐67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave‐processed formalin‐fixed paraffin sectionsThe Journal of Pathology, 1992